Here are 7 head-turning deal dispatches from the past week, as covered first on InvestingPro+.
1. Arco Platform (NASDAQ: ARCE ) announced it had received a non-binding going private proposal from General Atlantic and Dragoneer Investment Group for $11 per share, which represent an approximately 22% premium over the prior most recent closing price of $9.04.
The proposal states that the founders (Oto Brasil de Sá Cavalcante and Ari de Sá Cavalcante Neto) support the offer and will roll over 100% of their Class A common shares and Class B common shares in the transaction, and that after the closing, the founders will maintain the same economic and voting interest in the company as they currently have. The company cautions its shareholders and others considering trading in its securities that no decisions have been made with respect to the company's response to the proposal. Shares gained 43% to $12..41 for the week.
2. Hewlett Packard Enterprise (NYSE: HPE ) has expressed takeover interest in Nutanix (NASDAQ: NTNX ), according to a report from Bloomberg, citing people familiar with the matter. Nutanix shares gained 6.8% to $30.53. HPE shares rose 6.3% to $16.69.
3. Aerojet Rocketdyne (NYSE: AJRD ) is seeing multiple bidders, according to Reuters, which says General Electric (NYSE: GE ) L3Harris Technologies (NYSE: LHX ), Textron (NYSE: TXT ), and Veritas Capital are all vying to acquire the company. Aerojet shares gained 7.4% to $54.57 for the week.
4. EQT (NYSE: EQT ) is in talks to acquire Radius Global Infrastructure Inc (NASDAQ: RADI ) according to a report from Bloomberg, citing people with knowledge of the matter. EQT is speaking to banks about financing. No deal has been reached and talks could still collapse, the report cautioned. Radius shares gained 16.5% for the week to $12.88. EQT lost 3.7% to $39.93.
5. Shares of Horizon Therapeutics (NASDAQ: HZNP ) surged after the company confirmed that it was in "highly preliminary" takeover talks with Amgen Inc (NASDAQ: AMGN ), Janssen Global Services, LLC and Sanofi (EPA: SASY ) (NASDAQ: SNY ). The confirmation followed shortly after a Wall Street Journal article reported that the biopharma company was fielding takeover interest from large pharmaceutical companies. The Journal story added that with a typical takeover premium it could fetch a price well over $20 billion in a deal.
Horizon said the talks with the three parties "may or may not lead to an offer being made for the entire share capital of the Company." The company was forced to make the disclosure in accordance with Rule 2.6 of the Irish Takeover Rules, where it is based. Shares gained 34% for the week to $104.85.
6. Boston Scientific Corporation (NYSE: BSX ) agreed to acquire Apollo Endosurgery (NASDAQ: APEN ), Inc. for a cash price of $10 per share, reflecting an enterprise value of approximately $615 million. Shares gained 5.9% to $46.60 for the week.
If you’re interested in upgrading your search for new investing ideas, check out InvestingPro+
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.